Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Binion

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Digestive Diseases and Sciences|June 18, 2011
Postoperative infliximab is not associated with an increase in adverse events in Crohn's diseaseMiguel Regueiro, Sandra El-Hachem, Kevin E Kip, et al.
Gastroenterology|April 14, 2019
Inflammatory Bowel Disease Care Referral PathwayJami Kinnucan, David Binion, Raymond Cross, et al.
Inflammatory Bowel Diseases|May 17, 2021
Ustekinumab-Induced Remission of Two Cases of Refractory Cutaneous Crohn's DiseaseBansri M Patel, Claudia Ramos Rivers, Filippos Koutroumpakis, et al.
Inflammatory Bowel Diseases|July 2, 2014
Predictors of abdominal pain in depressed pediatric inflammatory bowel disease patientsArvind I Srinath, Alka Goyal, Lori A Zimmerman, et al.
American Journal of Physiology. Cell Physiology|January 19, 2022
Histone deacetylase inhibitors (HDACi) increase expression of KCa2.3 (SK3) in primary microvascular endothelial cellsAaron Kolski-Andreaco, Corina M Balut, Claudia A Bertuccio, et al.
Inflammatory Bowel Diseases|August 31, 2016
Genetic Predictors of Benign Course of Ulcerative Colitis-A North American Inflammatory Bowel Disease Genetics Consortium StudyUri Kopylov, Gabrielle Boucher, Matti Waterman, et al.
Inflammatory Bowel Diseases|July 12, 2016
Reinduction with Certolizumab Pegol in Patients with Crohn's Disease Experiencing Disease Exacerbation: 7-Year Data from the PRECiSE 4 StudyScott D Lee, David T Rubin, William J Sandborn, et al.
Crohn'S & Colitis 360|May 9, 2024
Clinical Decision Making in Inflammatory Bowel Disease Mimics: Practice Management from Inflammatory Bowel Disease LIVEHannah W Fiske, Christopher Ward, Samir A Shah, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Digestive Diseases and Sciences|June 18, 2011
Postoperative infliximab is not associated with an increase in adverse events in Crohn's diseaseMiguel Regueiro, Sandra El-Hachem, Kevin E Kip, et al.
Gastroenterology|April 14, 2019
Inflammatory Bowel Disease Care Referral PathwayJami Kinnucan, David Binion, Raymond Cross, et al.
Inflammatory Bowel Diseases|May 17, 2021
Ustekinumab-Induced Remission of Two Cases of Refractory Cutaneous Crohn's DiseaseBansri M Patel, Claudia Ramos Rivers, Filippos Koutroumpakis, et al.
Inflammatory Bowel Diseases|July 2, 2014
Predictors of abdominal pain in depressed pediatric inflammatory bowel disease patientsArvind I Srinath, Alka Goyal, Lori A Zimmerman, et al.
American Journal of Physiology. Cell Physiology|January 19, 2022
Histone deacetylase inhibitors (HDACi) increase expression of KCa2.3 (SK3) in primary microvascular endothelial cellsAaron Kolski-Andreaco, Corina M Balut, Claudia A Bertuccio, et al.
Inflammatory Bowel Diseases|August 31, 2016
Genetic Predictors of Benign Course of Ulcerative Colitis-A North American Inflammatory Bowel Disease Genetics Consortium StudyUri Kopylov, Gabrielle Boucher, Matti Waterman, et al.
Inflammatory Bowel Diseases|July 12, 2016
Reinduction with Certolizumab Pegol in Patients with Crohn's Disease Experiencing Disease Exacerbation: 7-Year Data from the PRECiSE 4 StudyScott D Lee, David T Rubin, William J Sandborn, et al.
Crohn'S & Colitis 360|May 9, 2024
Clinical Decision Making in Inflammatory Bowel Disease Mimics: Practice Management from Inflammatory Bowel Disease LIVEHannah W Fiske, Christopher Ward, Samir A Shah, et al.
Pageof 2